rs1861270

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372051.1(CASP8):​c.-27+1279A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.732 in 152,020 control chromosomes in the GnomAD database, including 41,088 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 41085 hom., cov: 31)
Exomes 𝑓: 0.88 ( 3 hom. )

Consequence

CASP8
NM_001372051.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.291

Publications

16 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.81 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP8NM_001372051.1 linkc.-27+1279A>G intron_variant Intron 1 of 8 ENST00000673742.1 NP_001358980.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP8ENST00000673742.1 linkc.-27+1279A>G intron_variant Intron 1 of 8 NM_001372051.1 ENSP00000501268.1 Q14790-1

Frequencies

GnomAD3 genomes
AF:
0.732
AC:
111198
AN:
151894
Hom.:
41046
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.788
Gnomad AMI
AF:
0.779
Gnomad AMR
AF:
0.584
Gnomad ASJ
AF:
0.634
Gnomad EAS
AF:
0.712
Gnomad SAS
AF:
0.830
Gnomad FIN
AF:
0.686
Gnomad MID
AF:
0.725
Gnomad NFE
AF:
0.739
Gnomad OTH
AF:
0.688
GnomAD4 exome
AF:
0.875
AC:
7
AN:
8
Hom.:
3
AF XY:
0.833
AC XY:
5
AN XY:
6
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.750
AC:
3
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.732
AC:
111284
AN:
152012
Hom.:
41085
Cov.:
31
AF XY:
0.729
AC XY:
54102
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.789
AC:
32713
AN:
41480
American (AMR)
AF:
0.583
AC:
8889
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.634
AC:
2201
AN:
3472
East Asian (EAS)
AF:
0.712
AC:
3681
AN:
5172
South Asian (SAS)
AF:
0.831
AC:
4007
AN:
4822
European-Finnish (FIN)
AF:
0.686
AC:
7202
AN:
10498
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.739
AC:
50210
AN:
67988
Other (OTH)
AF:
0.689
AC:
1456
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1508
3016
4525
6033
7541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.737
Hom.:
17900
Bravo
AF:
0.723
Asia WGS
AF:
0.799
AC:
2781
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
4.0
DANN
Benign
0.70
PhyloP100
-0.29
PromoterAI
0.0082
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1861270; hg19: chr2-202126615; COSMIC: COSV51846764; API